|
|
|
|
|
Session 81
Poster Presentations Isolation and Quantification of HIV-1 in Biological Specimens Session Day and Time: Tuesday 1:30 - 3:30 pm Room: Hall A |
Background: Suppression of HIV viral load by HART to < 50
copies/mL has been shown to correlate with favorable clinical outcome. Thus
viral load results reported as > 50 copies/mL in patients (pts) with
previously undetectable RNA, have potential clinical and psychological impact.
We investigated the distribution and analytic accuracy of results between 50
and 400 copies/mL for HIV-1 RNA quantitative assays performed by PCR or bDNA in
pts previously reported as < 50 copies/mL across a large diagnostics reference
laboratory system.
Methods: Clinical samples submitted for HIV RNA quantitative
assays performed at three Quest Diagnostics reference laboratories were
reviewed. Among more than 5,000 pt specimens assayed in Q2 and Q3, pts deemed
by their HIV care providers as having unexpected low positives (blips) ranging
from 50 copies to 1,000 had original and repeat blood-draw samples re-assayed
at a second laboratory (Nichols Institute) to assess their analytic veracity.
Results: Of results, 12.9% were reported as between 50 and
200 copies/mL. An additional 8.4% were between 201 and 500 copies/mL. The
distributions of results were not significantly different among the
laboratories performing the assays, though fewer patients < 50 copies/mL
were reported from the Southern USA with a corresponding increase in > 2,500.
The variance of bDNA results was less that that of PCR and the distributions
were different (p < 0.0001) with more < 50 by bDNA. But the proportion of
pts with 50 to 400 copies/mL was the same by both assays. Clinically unexpected
values (blips) were confirmed in 97% on the same specimen (within < 0.5 log
copies/mL) and within < 0.75 log copies in 94% on a subsequent specimen.
Conclusions: Low positive HIV RNA results (blips) are common
among pts under treatment and even when clinically unexpected are usually
confirmed by repeat or subsequent assays using either PCR or bDNA. While bDNA
results may vary less than PCR, rarely do blips appear to be due to analytic or
laboratory variance. The clinical significance of these blips remains
uncertain.